Stem Cell Research
Scope & Guideline
Transforming insights into impactful solutions.
Introduction
Aims and Scopes
- Induced Pluripotent Stem Cells (iPSCs) Generation:
The core focus of the journal is the generation of iPSC lines from various sources, including patients with specific genetic disorders, healthy donors, and other model organisms. This includes the application of advanced techniques such as CRISPR/Cas9 for gene editing. - Disease Modeling:
The journal frequently publishes research on the use of iPSCs to model a wide array of diseases, including neurodegenerative disorders, cardiac conditions, metabolic diseases, and genetic syndromes, providing insights into disease mechanisms and potential treatments. - Therapeutic Applications:
Research articles often explore the therapeutic implications of iPSCs, including their differentiation into specific cell types for transplantation and their use in drug screening and development. - Ethnic and Genetic Diversity in Stem Cell Research:
The journal highlights the importance of genetic diversity by publishing studies that include iPSC lines derived from diverse ethnic backgrounds and genetic profiles, aiming to enhance the applicability of stem cell therapies across different populations. - Technological Innovations:
Innovations in stem cell technologies, such as non-integrative reprogramming methods, advanced gene editing techniques, and the development of novel reporter lines for tracking differentiation and function, are also emphasized.
Trending and Emerging
- CRISPR/Cas9 and Gene Editing:
The use of CRISPR/Cas9 technology for gene editing in iPSCs is a rapidly growing area, with numerous studies focusing on creating specific gene knockouts or corrections to model diseases more accurately and develop potential therapies. - Personalized Medicine and Patient-Derived iPSCs:
There is a significant increase in research dedicated to generating patient-specific iPSCs for personalized medicine applications, particularly for diseases like Alzheimer's, Parkinson's, and various genetic disorders. - Applications in Regenerative Medicine:
Research that explores the application of iPSCs in regenerative medicine, including tissue engineering and organoid development, is on the rise, highlighting the potential for using iPSCs in clinical therapies. - Mental Health and Neurological Disorders:
The journal has seen an increase in studies focusing on the use of iPSCs to model mental health disorders, such as schizophrenia and autism, reflecting a growing interest in understanding the neurological basis of these conditions. - Ethnic Diversity in Stem Cell Research:
Emerging themes include the generation of iPSC lines from diverse ethnic groups to address health disparities and improve the applicability of stem cell therapies across different populations.
Declining or Waning
- Adult Stem Cell Research:
There has been a notable decrease in publications focusing solely on adult stem cells compared to iPSCs. This shift indicates a greater emphasis on iPSCs due to their versatility and the ability to generate patient-specific cell lines. - Basic Stem Cell Biology:
Research centered around the fundamental biology of stem cells, such as stem cell niche interactions and basic pluripotency mechanisms, appears to be waning as the field moves toward more applied research in disease modeling and therapy. - Non-human Stem Cell Models:
There has been a decline in papers utilizing non-human stem cell models (e.g., mouse or primate models) in favor of human-derived iPSCs, reflecting a trend towards research that is more directly applicable to human health. - Stem Cell Banking and Ethics:
Discussions and publications related to stem cell banking practices and the ethical implications of stem cell research have become less prominent, possibly due to the increasing normalization of iPSC research and clinical applications.
Similar Journals
BMC Molecular and Cell Biology
Championing high-quality insights in molecular and cell biology.BMC Molecular and Cell Biology is a forward-thinking open-access journal published by BMC, specializing in the vital fields of molecular biology and cell biology. Since its inception in 2019, the journal has carved a niche for itself, ranking in the Q3 quartile in both Cell Biology and Molecular Biology categories as of 2023. With an ISSN of N/A and an E-ISSN of 2661-8850, the journal provides a platform for groundbreaking research, high-quality reviews, and innovative methodologies. Situated in the United Kingdom, BMC Molecular and Cell Biology promotes a diverse range of studies, addressing fundamental questions in biology that resonate with both experts and new researchers alike. The journal's commitment to open access ensures that valuable findings are readily available to the global scientific community, fostering collaboration and knowledge-sharing across disciplines. Researchers aiming to contribute to the field of cell and molecular biology will find this journal an indispensable resource for both publishing and staying informed on the latest advances.
Stem Cell Reports
Transforming Insights into Regenerative MedicineStem Cell Reports, published by CELL PRESS, is a distinguished open access journal that has been providing critical insights into the dynamic field of stem cell research since its launch in 2013. With a focus on advancing knowledge in Biochemistry, Cell Biology, Developmental Biology, and Genetics, the journal holds a prestigious Q1 ranking across these categories in 2023, underscoring its significant impact and leadership within the scientific community. The journal occupies a prominent position in the Scopus rankings, notably achieving a remarkable percentile ranking in multiple disciplines, which reflects its rigorous peer-review process and the high quality of the research it disseminates. Accessible to a global audience, Stem Cell Reports not only facilitates the open exchange of innovative findings but also serves as a pivotal resource for researchers, professionals, and students dedicated to exploring the potential of stem cells in regenerative medicine and biotechnology. The journal is committed to supporting the advancement of the field by showcasing groundbreaking research and fostering collaboration among scientists worldwide.
ACTA HISTOCHEMICA
Exploring the Cellular Landscape Through Histochemical InnovationACTA HISTOCHEMICA, a prestigious journal published by Elsevier GmbH, is dedicated to advancing the field of histochemistry and its applications within cell biology and medicine. With an ISSN of 0065-1281 and an E-ISSN of 1618-0372, the journal provides a critical platform for the dissemination of high-quality research findings and reviews, integral for both emerging and established scholars. Since its inception in 1954 and continuing through to 2024, ACTA HISTOCHEMICA has maintained a strong commitment to publishing significant advancements in histology and cell biology, as evidenced by its categorization in Q3 for Cell Biology and Histology, as well as Q2 in miscellaneous medicine for the year 2023. The journal ranks favorably in Scopus, holding the 27th rank in Histology and a 200th rank in Cell Biology, highlighting its importance to the academic community. With its headquarters in Munich, Germany, ACTA HISTOCHEMICA continues to attract contributions from global researchers, fostering an international dialogue essential for the growth of knowledge in histochemistry and related disciplines.
Cell and Bioscience
Empowering Knowledge Sharing in Molecular BiologyCell and Bioscience is a prestigious open-access journal published by BMC that has been at the forefront of biochemistry, genetics, and molecular biology since its inception in 2011. With an impressive impact factor, this journal has established itself as a vital resource for researchers and professionals in these rapidly advancing fields, reflecting its high ranking of #29 out of 221 in the Scopus classification and placing it in the 87th percentile. Based in the United Kingdom, Cell and Bioscience aims to foster innovation and dissemination of research findings addressing critical biological questions through rigorous peer-reviewed articles and inter-disciplinary approaches. The journal's open-access model ensures unrestricted access to transformative research, promoting collaboration and knowledge sharing among academics, students, and practitioners worldwide. With a commitment to maintaining excellence in the field, Cell and Bioscience provides an essential platform for those looking to contribute to the evolving landscape of biosciences.
Cell Journal
Shaping the Future of Cell Science Through InnovationCell Journal is a leading interdisciplinary publication in the fields of Cell Biology, Developmental Biology, Molecular Biology, and Reproductive Medicine, published by ROYAN INST since its inception as an open-access journal in 2007. With an ISSN of 2228-5806 for print and 2228-5814 for electronic editions, it provides a vital platform for researchers and professionals to disseminate innovative findings and insights that shape our understanding of cellular processes and reproductive sciences. The journal boasts an impressive Scopus ranking, achieving a Q3 position in both Molecular Biology and Reproductive Medicine, highlighting its significance in the academic community. Situated in Tehran, Iran, Cell Journal encourages global collaboration through its accessible content, making cutting-edge research available to a diverse audience. As it converges from 2011 to 2024, the journal continues to emphasize the importance of thorough scientific inquiry, fostering advancements that drive both theoretical frameworks and practical applications in cell science.
Stem Cells International
Unlocking the Potential of Regenerative MedicineStem Cells International is a premier open access journal published by HINDAWI LTD, focusing on the rapidly evolving field of stem cell research. With an ISSN of 1687-966X and E-ISSN 1687-9678, this journal has been a vital resource since its inception in 2010, showcasing innovative studies and breakthroughs up to 2024. Positioned in Q3 in Cell Biology and Q2 in Molecular Biology for 2023, as well as well-ranked in the Scopus database, the journal serves as an essential platform for researchers, professionals, and students dedicated to exploring the implications of stem cell technology in regenerative medicine and biological research. The open access model ensures wide accessibility, fostering collaboration and knowledge-sharing across the scientific community, making it a cornerstone in advancing the understanding and application of stem cell science.
Current Stem Cell Reports
Elevating Research Standards in Stem Cell ApplicationsCurrent Stem Cell Reports, published by Springer Heidelberg, is an esteemed academic journal that has emerged as a pivotal resource in the fields of Cell Biology, Developmental Biology, Genetics, and Molecular Biology. Since its inception in 2015, this journal has consistently contributed to the evolving discourse on stem cell research and its applications, providing a platform for innovative studies and reviews through 2024. With a notable impact indicated by its quartile rankings—Q2 in Developmental Biology and Genetics, and Q3 in Cell Biology and Molecular Biology—it engages a diverse audience of researchers, professionals, and students who seek high-quality, accessible research insights. Although offering a traditional access model, the content remains vital for those invested in understanding the implications of stem cell advancements. Located in Switzerland and operating from the heart of Heidelberg, this journal aspires to bridge gaps in knowledge and stimulate collaboration in the burgeoning field of stem cell science.
Inflammation and Regeneration
Empowering discoveries in inflammation and regenerative therapies.Inflammation and Regeneration is a prominent open-access journal published by BMC, focused on the discerning fields of immunology, cell biology, and regenerative medicine. Since its establishment in 2016, the journal has provided a platform for the dissemination of high-quality research, contributing significantly to the advancement of knowledge in inflammation processes and regenerative therapies. With a remarkable impact reflected in its Q1 quartile rankings in Cell Biology and Immunology for 2023, Inflammation and Regeneration stands out as a leading resource for researchers and practitioners. The journal's commitment to open access ensures that critical findings are readily available to a global audience, fostering collaboration and innovation in the scientific community. With a Scopus ranking that places it in the top 20% of its categories, Inflammation and Regeneration serves as an essential reference for those seeking to stay at the forefront of immunological research and its applications.
Genes & Diseases
Unlocking the secrets of genes to combat diseases.Genes & Diseases, published by KEAI PUBLISHING LTD, is a premier open-access journal dedicated to advancing the fields of genetics, biochemistry, and molecular biology. Established in 2014 and headquartered in Beijing, China, this journal has quickly risen to prominence, securing a place in the prestigious Q1 quartile in Biochemistry and Genetics (clinical), as well as Q2 in Cell Biology and Q1 in Molecular Biology as of 2023. With a commitment to disseminating cutting-edge research, Genes & Diseases serves as a critical platform for researchers, professionals, and students alike, ensuring that high-quality scientific work is openly accessible to the global community. The journal's exceptional impact is underscored by its selective Scopus rankings, which reflect its influence and relevance in key scientific domains, making it an essential resource for those exploring the intersections of genetics and disease pathology.
International Journal of Stem Cells
Pioneering Discoveries in Developmental BiologyThe International Journal of Stem Cells is a distinguished peer-reviewed journal dedicated to advancing the field of stem cell research. Published by the Korean Society for Stem Cell Research, this journal has established itself as a vital source of high-quality research since its inception in 2008. Operating under the ISSN 2005-3606 and E-ISSN 2005-5447, the journal caters to a global audience, featuring works that span a diverse array of topics within Cell Biology and Developmental Biology. It is noteworthy that as of 2023, the journal is ranked Q3 in Cell Biology and Q2 in Developmental Biology, highlighting its growing influence and credibility in the scientific community. Given its commitment to facilitating open scientific communication, it is crucial for researchers, professionals, and students to engage with the rigorous research published in this journal as it profoundly impacts the understanding and application of stem cell science. With accessibility to a wealth of innovative studies, the International Journal of Stem Cells remains an indispensable resource for anyone interested in the transformative potential of stem cell research.